Obesity Science and the New Era of Obesity Medicines, Endocrine Society,
Staphylococcus aureus Bacteraemia: Evaluation and Management, IDSA/ESCMID,
Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management, AHA,
Pulmonary Arterial Hypertension: Treatment Guideline Update, ERS,
Antiarrhythmic Drugs in Understudied Clinical Scenarios, HRS/PACES,
Care of the Tactical Athlete With Cardiovascular Abnormalities, ACC/AHA,
Kidney Health Guidance for CKM Syndrome, ASN,
Residual Lesions and Early Reinterventions After Pediatric Cardiac Surgery, AHA,
2026 ESC Guidelines for Cardiovascular Disease and CKD, ESC/ERA,
2026 ESC Guidelines for Heart Failure, ESC,
2026 ESC Guidelines on Cardiac Rehabilitation, ESC,
2026 Guideline for Adult Stroke Rehabilitation and Recovery, AHA/ASA,
Fifth Universal Definition of Myocardial Infarction, ESC/ACC/AHA/WHF,
2026 AHA/ACC Performance and Quality Measures for Atrial Fibrillation, AHA/ACC,
Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease, ACC,
Adult Immunizations as Part of Cardiovascular Care, ACC,
Follow-up Extensions in Cardiovascular Trials: Methodologic Standards, AHA,
Inflammation in Coronary Syndromes, ESC/ACVC,
Pulmonary Valve Replacement Options After Tetralogy of Fallot Repair, STS/WSPCHS/ECHSA,
Management of Heart Failure With Preserved Ejection Fraction, ACC,
Diagnosis of Light Chain Amyloidosis, ASH,
Tricuspid Valve Endocarditis in People Who Inject Drugs, STS,
Enhanced Radiation Protection in Cardiovascular Procedures, SCAI/ASE/HRS/SIR/SVS,
Ischemic Stroke Risk With Left Ventricular Systolic Dysfunction, AHA,
Antiplatelet Therapy in Atherosclerotic Cardiovascular Disease, ACC,
Direct Oral Anticoagulants for Prevention of Thrombotic Events, ACC,
Second Universal Definition of Heart Failure, AHA/ACC/ESC/WHF,
Prevention of Invasive Aspergillosis After Solid Organ Transplantation, IDSA,
Heart Failure in the Perinatal Period, AHA,
Perioperative Anemia and Blood Management in Cardiac Surgery, AHA,
Optimizing Heart Failure Care in Older Adults, AHA,
Cardiovascular Endpoints in Oncology Trials, AHA,
2026 Guideline for Cardiovascular-Kidney-Metabolic Syndrome, AHA/ACC/ADA/ASN,
Using Predicted Risk and Expected Benefit in CKM Syndrome, AHA/ACC,
Anticoagulation for Cardiac Surgery in Heparin-Induced Thrombocytopenia, ISTH,
Physical Activity in Obesity Treatment and Cardiometabolic Health, AHA,
Prevention of Heart Failure, ESC/HFA/EAPC/ACNAP,
Cardiovascular Disease in Adults With Cancer, IC-OS/MASCC,
Transseptal Puncture in Cardiovascular Interventions, EHRA/HFA/EAPCI/EACVI/AEPC,
Ethical Considerations for Heart Organ Allocation, AHA,
Coronary Microvascular Obstruction: Prevention and Management, ESC/EAPCI,
The Kidney in Cardiovascular-Kidney-Metabolic Syndrome, KDIGO,
Cardiovascular Care During the Postpartum Period, ACC,
Cardiac Involvement in Eosinophilia, ESC,
Observational Comparative Research in Cardiovascular and Brain Health, AHA,
International Collaboration for Better Kawasaki Disease Outcomes, AHA,
Artificial Intelligence in Peripheral Artery Disease, AHA,
Secondary Prevention After Coronary Artery Bypass Surgery: 2026 Update, AHA,
Mechanical Complications of Acute Myocardial Infarction, ESC/EACTS,
Early Diagnosis of Light Chain Amyloidosis, BSH,
Detecting and Mitigating Bias in Clinical Research, AHA,
Evaluation and Management of Recent-Onset Cardiomyopathy, ESC/HFA,
2026 CIED Lead Management and Extraction, HRS/AHA/APHRS/EHRA/IDSA/LAHRS/PACES/STS,
Heart Failure With Mildly Reduced Ejection Fraction, HFSA,
Indications and Timing of Pulmonary Valve Replacement After Tetralogy of Fallot Repair, STS/WSPCHS/ECHSA,
Artificial Intelligence in Clinical Electrophysiology, HRS,
Digital Health for Lifestyle and Risk-Factor Management in Atrial Fibrillation, HRS,
New-Onset Atrial Fibrillation After Cardiac Surgery, STS,
Masters Athletes With Abnormal Cardiovascular Findings, ESC/EAPC/ACC,
2026 Dietary Guidance for Cardiovascular Health, AHA,
Gene Editing Therapy in Cardiovascular Disease, ACC,
Nonoptimal Temperature and Cardiovascular Health, AHA,
Outpatient Management of Left-to-Right Shunts in Children, ACC,
Operator and Institutional Requirements for Tricuspid Interventions, ACC/AHA/ASE/HRS/STS,
Management of Blunt Thoracic Aortic Injury: Focused Update, SVS,
Genetic Counselling for Dilated Cardiomyopathy, ESC/HFA,
2026 Guideline on the Management of Dyslipidemia, ACC/AHA multisociety,
Risk Stratification and Management of MASLD, AGA,
Cardiovascular Metabolic Mechanisms in Heart Failure, ESC/HFA,
Kidney Disease and Heart Failure: Advances and Challenges, KDIGO,
Reference Values for Cardiopulmonary Exercise Testing, ERS,
Dyslipidemia in Children: Diagnosis and Management, CPS,
Cardiovascular Disease and Stroke Burden in Women Through 2050, AHA,
2026 Guideline for Acute Pulmonary Embolism in Adults, AHA/ACC and partner societies,
Pulsed Field Ablation for Cardiac Arrhythmias, HRS/EHRA,
Evaluating Cardiovascular Risk Models, Biomarkers, and Tools, AHA,
Best Practices for Adult Congenital Heart Disease Electrophysiology Programs, HRS/ISACHD/PACES,
Coronary Atherosclerosis in Patients With Cancer and Survivors, AHA,
Direct Oral Anticoagulants in Adult Cardiac Surgery, SCA/STS,
Maternal Stroke in Pregnancy and Postpartum, AHA (ACOG-endorsed),
Integrated Health Technologies in Heart Failure, HFSA/AAHFN,
2026 ACC/AHA Performance and Quality Measures for Peripheral Artery Disease, ACC/AHA,
Circulatory Shock and Haemodynamic Monitoring, ESICM,
Post-Resuscitation Care, ERC/ESICM,
Emergencies in Patients on ECMO, ICS and partner societies,
Fluid Therapy in Critically Ill Adults, Part 3: Fluid Removal, ESICM,
Intraoperative Haemodynamic Management for Noncardiac Surgery, ESAIC,
Fluid Therapy in Critically Ill Adults, Part 2: Resuscitation Volume, ESICM,
Adult Critical Care Ultrasonography: Focused Update, SCCM,
Preoperative Assessment for Elective Noncardiac Surgery, ESAIC,
Treatment of Systemic Sclerosis, EULAR,
Management of Systemic Sclerosis, BSR,
Perioperative Venous Thromboembolism Prophylaxis, ESAIC and partner societies,
